{"id":817113,"date":"2025-02-24T16:42:08","date_gmt":"2025-02-24T21:42:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/"},"modified":"2025-02-24T16:42:08","modified_gmt":"2025-02-24T21:42:08","slug":"ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/","title":{"rendered":"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN RAFAEL, Calif., Feb.  24, 2025  (GLOBE NEWSWIRE) &#8212; Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2024 after the close of trading on Monday, March 3, 2025. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to review the financial results and discuss recent business developments.<\/p>\n<p align=\"justify\">To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4fDwBMbraM_YdHCwJN_Ds0NWOMy-zav45AU34G2Df4LdZZ5FA61_HemaqfvWO2wkFtiVxiyLEB5gjtSvGCkbK5mnnxwfDYF3CTFBlWsrHgU=\" rel=\"nofollow\" target=\"_blank\">www.eksobionics.com<\/a> under \u201cPresentations &amp; Events\u201d in the Investors section.<\/p>\n<p align=\"justify\">\n        <strong>About Ekso Bionics<\/strong><br \/>\n        <sup><br \/>\n          <strong>\u00ae<\/strong><br \/>\n        <\/sup><br \/>\n        <br \/>Ekso Bionics<sup>\u00ae<\/sup> is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol \u201cEKSO.\u201d For more information, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4fDwBMbraM_YdHCwJN_Ds5MMM_YIZfD17MXpH950Gil03zi7NnDrtbqzVTxwcAEy1Jvfw9ji1kG653kDqlpoxBABv6clGRwKBUewoDaDQZ4=\" rel=\"nofollow\" target=\"_blank\">www.eksobionics.com<\/a> or follow @EksoBionics on X.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Stephen Kilmer<br \/>Investor Relations<br \/>Direct: (646) 274-3580<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O30xuOVoyAhIuKgOEskaFCsMuhBYkHwcIsDsRU7gxuVSPCEPg-mPpB0kw1I0_vr686uIySM8ROsN8Ts8Cnzodh9yQKE83cHmBtLgVkggYjk=\" rel=\"nofollow\" target=\"_blank\">skilmer@eksobionics.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWZlZjJjYTYtNzEzZS00Njc2LWI2N2MtNzdlMTVjZmY3NmM2LTEwMzkwNjY=\/tiny\/Ekso-Bionics-Holdings-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2024 after the close of trading on Monday, March 3, 2025. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to review the financial results and discuss recent business developments. To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company\u2019s website at www.eksobionics.com under \u201cPresentations &amp; Events\u201d in the Investors section. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-817113","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2024 after the close of trading on Monday, March 3, 2025. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to review the financial results and discuss recent business developments. To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company\u2019s website at www.eksobionics.com under \u201cPresentations &amp; Events\u201d in the Investors section. About &hellip; Continue reading &quot;Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T21:42:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow\",\"datePublished\":\"2025-02-24T21:42:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/\",\"name\":\"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=\",\"datePublished\":\"2025-02-24T21:42:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/","og_locale":"en_US","og_type":"article","og_title":"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow - Market Newsdesk","og_description":"SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2024 after the close of trading on Monday, March 3, 2025. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to review the financial results and discuss recent business developments. To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company\u2019s website at www.eksobionics.com under \u201cPresentations &amp; Events\u201d in the Investors section. About &hellip; Continue reading \"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-24T21:42:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow","datePublished":"2025-02-24T21:42:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/","name":"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=","datePublished":"2025-02-24T21:42:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzU3NiM2Nzc1NjUxIzIwMjc5MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-3-conference-call-to-follow\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 \u2013 Conference Call to Follow"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=817113"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817113\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=817113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=817113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=817113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}